Pharmaceutical compound
Clinical data | |
---|---|
Trade names | Doyle |
Other names | TA-058 |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.162.655 |
Chemical and physical data | |
Formula | C21H27N5O7S |
Molar mass | 493.54 g·mol |
Aspoxicillin (trade name Doyle) is an antibiotic drug of the beta-lactam class. It is an injectable form of penicillin that is highly active against Gram-positive and Gram-negative bacteria, including Bacillus fragilis, which is resistant to other beta-lactam antibiotics. It is approved for use in Japan.
References
- ^ "Aspoxicillin". IUPHAR/BPS Guide to Pharmacology.
- Matsumoto K (July 1987). "". The Japanese Journal of Antibiotics. 40 (7): 1221–1242. PMID 3316732.
- "Aspoxicillin". Inxight Drugs. National Center for Advancing Translational Sciences.
- Edwards R (December 1997). "Resistance to beta-lactam antibiotics in Bacteroides spp". Journal of Medical Microbiology. 46 (12): 979–986. doi:10.1099/00222615-46-12-979. PMID 9402919.
This systemic antibiotic-related article is a stub. You can help Misplaced Pages by expanding it. |